SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-121252
Filing Date
2006-05-30
Accepted
2006-05-30 17:13:28
Documents
3
Period of Report
2006-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13895
2 PRESS RELEASE dex991.htm EX-99.1 9208
3 GRAPHIC g81830img.jpg GRAPHIC 29051
  Complete submission text file 0001193125-06-121252.txt   64907
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 06874768
SIC: 2836 Biological Products, (No Diagnostic Substances)